GLPwatch
Trials (2139)
Page 4 of 36.
- Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
- Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
- The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
- Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
- Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
- Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
- Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
- Effect of Itopride on Semaglutide Gastroparesis
- Effect of Liraglutide on Clock Genes
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
- In-patient Study in Patients With Type 2 Diabetes Mellitus
- Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- Retrospective Analysis for Patients With Metabolic Syndrome
- Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
- Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
- A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
- Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
- Young Adults With Early-onset Obesity Treated With Semaglutide
- Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
- Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
- GLP1R Polymorphisms and Response to GLP1
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
- Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
- A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
- Tailored Exercise Training Study Among Adults With HFpEF
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
- The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
- Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effects of Semaglutide on Nicotine Intake
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
- SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.